Just for clarification, Ms. Brown pointed out three areas of conversation. To clarify, then, one is health care wait lists, on which we've already agreed we're going to have an exploratory meeting. Two is prescription drugs, if I'm hearing Ms. Brown correctly. She had tied in numbers 7 and 13; I guess number 5, bulk drug exports, could also be tied into that.
On May 16th, 2006. See this statement in context.